Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Germany Italy The Netherlands Poland +1
  • Study on the Safety of Lutetium (177Lu) Oxodotreotide, L-Lysine Hydrochloride, and L-Arginine Hydrochloride in Adolescents with Neuroendocrine Tumors and PPGLs

    Not recruiting

    2 1 1 1
    France Poland Spain
  • Study on the Effects of Fordadistrogene Movaparvovec for Patients with Duchenne Muscular Dystrophy

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy Spain
  • Study of G1XCGD Lentiviral Vector in Patients with X-Linked Chronic Granulomatous Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    France
  • Study Comparing Aliskiren and Enalapril for Patients with C3 Glomerulopathy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Sweden
  • Study on the Safety and Effectiveness of Diamyd and Colecalciferol for Adolescents and Adults with Recently Diagnosed Type 1 Diabetes

    Not recruiting

    3 1 1
    Czechia Estonia Germany Hungary The Netherlands Poland +2
  • Study on the Effect of Human Normal Immunoglobulin on Lung Disease in Patients with Primary Antibody Deficiency

    Not recruiting

    3 1 1 1
    The Netherlands
  • Study on the Effectiveness of Inavolisib, Atezolizumab, and Entrectinib in Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    Belgium Denmark France Germany Italy Poland +2
  • Study on the Effects of Subcutaneous Human Immunoglobulin (Newnorm) for Patients with Primary Immunodeficiency Diseases

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Hungary Italy Poland Slovakia
  • Study of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Spain